Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Investigates the synthesis of hybrid sp2-sp3 compounds in pharmaceuticals, indicating new possibilities for drug development.
Aromatics are indispensable structural motifs in pharmaceuticals due to conformational rigidity, unique noncovalent interactions, and stability, but they can also bear negative consequences related to poor solubility and metabolism. On the other hand, sp 3 ‐hybridized structures address many of the deficiencies of aromatic counterparts. Based on this, we designed a systematic platform for the synthesis of hybrid sp 2 ‐sp 3 building blocks via benzyne cycloadditions, aiming to exploit a synergetic effect and explore new chemical space. The application of this strategy is demonstrated in the synthesis of Enalapril hybrid derivatives.
Saraci et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: